| Evinacumab for homozygous familial hypercholesterolemia FJ Raal, RS Rosenson, LF Reeskamp, GK Hovingh, JJP Kastelein, ... New England Journal of Medicine 383 (8), 711-720, 2020 | 576 | 2020 |
| Combination lipid-lowering therapy as first-line strategy in very high-risk patients KK Ray, LF Reeskamp, U Laufs, M Banach, F Mach, LS Tokgözoğlu, ... European Heart Journal 43 (8), 830-833, 2022 | 151 | 2022 |
| ANGPTL3 inhibition with evinacumab results in faster clearance of IDL and LDL apoB in patients with homozygous familial hypercholesterolemia—brief report LF Reeskamp, JS Millar, L Wu, H Jansen, D van Harskamp, H Schierbeek, ... Arteriosclerosis, thrombosis, and vascular biology 41 (5), 1753-1759, 2021 | 81 | 2021 |
| Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia LF Reeskamp, JJP Kastelein, PM Moriarty, PB Duell, AL Catapano, ... Atherosclerosis 280, 109-117, 2019 | 55 | 2019 |
| Transintestinal cholesterol excretion in humans LF Reeskamp, ECE Meessen, AK Groen Current opinion in lipidology 29 (1), 10-17, 2018 | 55 | 2018 |
| Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study D Collard, NS Nurmohamed, Y Kaiser, LF Reeskamp, T Dormans, ... BMJ open 11 (2), e045482, 2021 | 47 | 2021 |
| Next-generation sequencing to confirm clinical familial hypercholesterolemia LF Reeskamp, TR Tromp, JC Defesche, A Grefhorst, ESG Stroes, ... European journal of preventive cardiology 28 (8), 875-883, 2021 | 45 | 2021 |
| Marked plaque regression in homozygous familial hypercholesterolemia LF Reeskamp, NS Nurmohamed, MJ Bom, RN Planken, RS Driessen, ... Atherosclerosis 327, 13-17, 2021 | 45 | 2021 |
| Taking One Step Back in Familial Hypercholesterolemia: STAP1 Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and Humans N Loaiza, ML Hartgers, LF Reeskamp, JW Balder, A Rimbert, V Bazioti, ... Arteriosclerosis, thrombosis, and vascular biology 40 (4), 973-985, 2020 | 40 | 2020 |
| Intranasal corticosteroids for non‐allergic rhinitis C Segboer, A Gevorgyan, K Avdeeva, S Chusakul, J Kanjanaumporn, ... Cochrane Database of Systematic Reviews, 2019 | 39 | 2019 |
| Ethnicity, lipids and cardiovascular disease K Gazzola, L Reeskamp, BJ van den Born Current opinion in lipidology 28 (3), 225-230, 2017 | 39 | 2017 |
| The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease? LF Reeskamp, TR Tromp, ESG Stroes Current opinion in lipidology 31 (3), 140-146, 2020 | 37 | 2020 |
| Familial hypercholesterolemia: the most common monogenic disorder in humans JJP Kastelein, LF Reeskamp, GK Hovingh Journal of the American College of Cardiology 75 (20), 2567-2569, 2020 | 37 | 2020 |
| Joint genetic inhibition of PCSK9 and CETP and the association with coronary artery disease: a factorial mendelian randomization study AJ Cupido, LF Reeskamp, AD Hingorani, C Finan, FW Asselbergs, ... JAMA cardiology 7 (9), 955-964, 2022 | 36 | 2022 |
| ABCG5 and ABCG8 genetic variants in familial hypercholesterolemia LF Reeskamp, A Volta, L Zuurbier, JC Defesche, GK Hovingh, A Grefhorst Journal of clinical lipidology 14 (2), 207-217. e7, 2020 | 36 | 2020 |
| Lipoprotein (a), venous thromboembolism and COVID-19: A pilot study NS Nurmohamed, D Collard, LF Reeskamp, Y Kaiser, J Kroon, TR Tromp, ... Atherosclerosis 341, 43-49, 2022 | 35 | 2022 |
| Novel lipid modifying drugs to lower LDL cholesterol AJ Cupido, LF Reeskamp, JJP Kastelein Current opinion in lipidology 28 (4), 367-373, 2017 | 32 | 2017 |
| A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia: Time to Widen the Scope? LF Reeskamp, ML Hartgers, J Peter, GM Dallinga-Thie, L Zuurbier, ... Circulation: Genomic and Precision Medicine 11 (12), e002385, 2018 | 30 | 2018 |
| Advances, gaps and opportunities in the detection of familial hypercholesterolemia: overview of current and future screening and detection methods S Ibrahim, LF Reeskamp, ESG Stroes, GF Watts Current opinion in lipidology 31 (6), 347-355, 2020 | 27 | 2020 |
| Systematic review: pharmacotherapy for high‐output enterostomies or enteral fistulas FEE De Vries, LF Reeskamp, O Van Ruler, I Van Arum, W Kuin, G Dijksta, ... Alimentary pharmacology & therapeutics 46 (3), 266-273, 2017 | 26 | 2017 |
GK Hovinghdept Vascular Medicine, Academic Medical Center在 amc.uva.nl 的电子邮件经过验证
